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Background: Physical activity (PA) reduces pain and improves functioning in people with knee osteoarthritis (OA),
but few people with the condition meet recommended PA guidelines. Successful intervention strategies to increase
PA include goal setting, action planning, self-monitoring, and follow-up feedback from a healthcare professional.
Recently developed consumer wearable activity trackers allow users to set activity goals, self-monitor daily
goal-progress, and provide feedback on goal attainment. It is hypothesized that a multi-component physiotherapist-led
intervention that includes a short (40-min) education module, guided goal-setting and action planning, the use
of a wristband activity tracker, and weekly follow-up phone calls will lead to increased PA outcomes.
Methods/design: Thirty-six participants will be recruited from the community for a two-group pilot randomized
controlled trial with a stepped-wedge design using an intention-to-treat analysis. Computer-generated block
randomization will be performed using varying block sizes and a 1:1 allocation ratio. The 4-week intervention will
be delivered immediately (immediate-intervention group) or after a 5-week delay (delayed-intervention group).
Outcome measures of pain and disability (Knee Injury and OA Outcome Score), disease self-management ability
(Partners in Health Scale), and objective bouted moderate-to-vigorous PA and sedentary time (BodyMedia SenseWear
Mini Armband) will be collected at baseline (week 0) and two follow-ups (weeks 5 and 10), for a total study duration of
11 weeks. Feasibility data relating to process, resource, management, and scientific elements of the trial will be
collected. Outcome measure and feasibility data will be summarized, and an estimate of intervention efficacy will
be obtained by regression model with planned comparisons. The trial began recruiting in February 2015. To date,
34 subjects have been recruited.
Discussion: This study will evaluate the feasibility and preliminary efficacy of a novel intervention to promote PA
in people living with knee OA. The results will provide valuable information to inform a larger randomized trial to
assess intervention effectiveness.
Trial registration: ClinicalTrials.gov Identifier: NCT02313506 (registration date 8 December 2014). First participant
randomized 20 February 2015.
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Osteoarthritis (OA) is the most common chronic joint
disease, affecting 10–15 % of people in North America
[1]. The knee joint is most commonly affected, with
knee OA a leading cause of chronic pain and functional
limitation that can decrease one’s ability to participate in
daily activities and reduce quality of life [2]. Due to in-
creasing rates of obesity and aging population demo-
graphics, the prevalence of OA in Canada is projected to
more than double within a generation with associated
costs (CAD$27.5 billion in 2010) projected to increase
to CAD$1.45 trillion by 2040 [3].
OA remains a condition with no cure, and current
non-surgical treatments are aimed at alleviating symp-
toms while maintaining high quality of life. Physical ac-
tivity (PA) is a core first-line treatment [4, 5], with both
aerobic exercise and strength training known to safely
reduce pain and improve functioning in this population
[6–12]. A 2015 Cochrane review reported people with
knee OA who exercised experienced a 12 % decrease in
pain, 10 % improvement in physical function, and 4 %
improvement in quality of life immediately following
treatment [13]. Regular PA is also known to provide
global health benefits that help manage or prevent
chronic comorbidities such as hypertension, cardiovas-
cular disease, or diabetes that commonly develop in
people with this condition [14]. National PA guidelines
state that all adults should participate in at least
150 min of moderate-to-vigorous PA (MVPA) per week
in bouts of 10 min or more to obtain the health bene-
fits of an active lifestyle [14].
Despite these recommendations, the knee OA popula-
tion remains highly inactive. People living with knee OA
spend roughly 10 h of their waking day in sedentary be-
haviours [15] and obtain 50 min per week of MVPA
[16]. As few as 13 % of this population meet recom-
mended activity guidelines [17, 18]. Insufficient PA in
the knee OA population is particularly concerning given
the emerging association of sedentary behaviour with
poor health outcomes, including increased risk of meta-
bolic syndrome, cardiovascular disease, diabetes, myocar-
dial infarction, and all-cause mortality [19–22]. Reflective
of this, Australian PA guidelines now recommend break-
ing up sitting time as often as possible throughout the day
[23]. Greater levels of sedentary behaviour independent of
MVPA participation have also been associated with poorer
physical functioning in people with knee OA [15, 16]. As
such, there is a clear need to promote greater activity
levels and reduced sedentary time in this population.
PA promotion interventions among chronic disease
populations have varied in format, setting, mode of de-
livery, and techniques employed to elicit behaviour
change. A 2008 systematic review and meta-analysis
found PA promotion interventions among chronicallyill populations yielded a small-to-moderate effect size
(ES = 0.45; 95 % confidence interval (CI) 0.38, 0.52) that
was associated with 945 additional steps per day and 48
additional PA minutes per week. Interventions employ-
ing behaviour-oriented strategies such as goal setting,
action plan formation, self-monitoring, and provision of
feedback were associated with higher effect sizes than
interventions focusing on education or cognitive strat-
egies (such as motivational counseling or problem solv-
ing) alone [24]. Evidence has also been emerging
supporting the use of wearable activity trackers such as
pedometers or accelerometers for PA promotion. Activ-
ity trackers provide an objective measurement of activity
output that facilitates goal setting and self-monitoring
while serving as an environmental cue towards activity
[25]. A 2009 meta-analysis of trials that used pedometers
to promote PA found intervention participants took
2491 more steps per day relative to control groups
(95 % CI 1098; 3885 steps per day) across eight trials,
with significant but modest accompanying decreases in
BMI and blood pressure [26]. Pedometer interventions
have also been effectively employed in arthritis popula-
tions. For example, Talbot et al. combined a pedometer-
driven walking program aimed at incrementally increasing
daily step counts with self-management education for
people with knee OA and compared this program to a
group receiving self-management education alone. The
intervention group achieved a 23 % increase in daily steps,
as well as a statistically significant increase in isometric
strength, suggesting arthritis populations may also benefit
from the use of these devices [27].
Following recent technological improvements, sophis-
ticated accelerometer-based activity trackers are now
available for consumer use as motivational tools to in-
crease PA. These devices offer a host of features unavail-
able to the pedometer, including the ability to track
intensity of activities as opposed to steps only, and user-
friendly smartphone or web-based interfaces that graph-
ically depict activity over time. Modern activity trackers
encourage users to set specific activity goals (e.g. num-
ber of steps) and monitor progress throughout the day,
providing immediate feedback on goal achievement. As
an additional benefit, web-based hosting and social net-
work functionality of the user-interfaces facilitate ease of
communication about activities between individuals and
their healthcare team. Owing to their recent develop-
ment, few studies report employing these devices as PA
promotion tools; however, a systematic content analysis
of consumer wearables concluded the devices featured a
number of evidence-based techniques for promoting PA
[25]. Additionally, results from studies in 2013 and 2015
employing a clip-on activity tracker noted significant in-
creases in light, moderate, and vigorous PA and decreases
in sedentary time [28, 29], whereas use of an armband
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tions led to weight loss in overweight and obese subjects
[30, 31]. While various models of wearable trackers are
presently available (e.g. hip clip-ons, wristbands, ankle-
straps), a popular consumer wristband accelerometer, the
Fitbit Flex (Fitbit Inc., San Francisco, CA, USA), demon-
strated high ratings of wearability and usability in a prior
pilot study among arthritis patients conducted by our
group [32]. Thus, the proposed study outlines a pilot ran-
domized controlled trial of a novel PA intervention that
leverages evidence-based behaviour-change techniques
and the Fitbit Flex activity tracker to promote greater ac-
tivity levels among people living with knee OA.
Objectives and hypotheses
The primary objectives of the present study are to
pilot and collect feasibility data on trial processes, re-
sources, and management and to assess the prelimin-
ary efficacy of a PA promotion intervention for increasing
bouted MVPA in people with knee OA. The proposed
intervention consists of three components: (1) a 1.5-h in-
person small group session including a physiotherapist-led
education module, personalized activity counseling, and
action planning; (2) the use of a Fitbit Flex activity
tracker; and (3) weekly physiotherapist follow-up phone
calls to modify activity levels as needed. Secondary ob-
jectives related to efficacy include assessing if the inter-
vention decreases bouted sedentary time, improves
knee OA disease severity, and improves perceptions of
self-management ability.
It is hypothesized that the intervention will: (1) in-
crease bouted MVPA time (bout ≥ 10 min), (2) de-
crease bouted sedentary time (bout ≥ 20 min), (3)
increase perceptions of self-management ability, (4)
decrease pain, and (5) increased functional ability in
people with knee OA.
Methods/design
This protocol is guided by the Standard Protocol Items:
Recommendations for Intervention Trials (SPIRIT) 2013
guidelines [33]. This study has received approval from
the University of British Columbia Clinical Research
Ethics Board (H14-02631), and the study was registered
on ClinicalTrials.gov (NCT02313506).
Study design
The TRACK-OA study will be carried out at the Arthritis
Research Canada (Richmond, BC, Canada) and the Mary
Pack Arthritis Centre (Vancouver, BC, Canada). Par-
ticipants will be recruited from the community in the
Greater Vancouver Area. The study is a two-group
pilot randomized controlled trial (RCT) with a
stepped-wedge design. The stepped-wedge is a trial
design in which all participants receive the interventionbut the time point at which the intervention is received is
randomized (immediate, or after a 5-week delay) (see Fig. 1
for trial flowchart). After receiving informed consent from
the participants, baseline measures will be collected.
Participants
A convenience sample of 36 participants will be recruited
from the community by way of community posters and
web-based advertisements. Interested participants will
complete a web-based screening questionnaire and eligible
participants are phoned for further screening, obtainment
of informed consent, and study enrollment.
Eligibility criteria
Participants are included if they (1) possess a physician-
confirmed diagnosis of knee OA or are both over 50 years
and have experienced 4 weeks of pain, aching, or discom-
fort in or around the knee during the last year (equal to or
more than 28 separate or consecutive days) [34]; (2) have
no previous diagnosis of inflammatory arthritis, connect-
ive tissue diseases, fibromyalgia, or gout; (3) have no his-
tory of using disease-modifying anti-rheumatic drugs or
gout medications; (4) have no prior knee arthroplasty;
(5) are not on the waitlist to receive total knee arthro-
plasty; (6) have no history of acute knee injury in the
past 6 months; (7) have not had lower extremity or
back surgery in the past 12 months; and (8) have an
email address and daily access to a personal computer
with internet access.
Individuals are excluded if they (1) have a BMI of
≥40 kg/m2, (2) have received a steroid injection in a
knee in the last 6 months, (3) have received a hyalur-
onate injection in a knee in the last 6 months, (4) are
using medications that impair activity tolerance (such
as beta-blockers), and (5) have an inappropriate level
of risk for increasing their unsupervised PA as identi-
fied by the Physical Activity Readiness Questionnaire
(PAR-Q) 2014 [35]. Specifically, if an individual an-
swers “Yes” to any conditions described in the General
Health Questions section, they will complete a series of
standardized follow-up questions. Any individual who
does not pass the PAR-Q will require physician clearance
to participate, and those with severe health issues such as
a heart or cardiovascular condition will be deemed ineli-
gible under this criterion. In some cases, an individual
may fail the PAR-Q on the basis of their knee OA alone.
In these instances, further clarification questions will be
asked to determine whether physician clearance is re-
quired as per the procedure outlined in Table 1.
Outcome measures
Descriptive measures
Demographic information including age, gender, in-
come, level of education, height, weight, presence of
Recruitment
Assessed for eligibility
Baseline Assessment [Week 0]
Bouted MVPA time, bouted sedentary time (SenseWear Mini Armband), KOOS, PIH 
Demographic Data
Randomization of participants
Immediate-intervention group
Education/action-planning session; Fitbit 
Flex; weekly phone calls and emails as 
needed with PT to revisit activity goals 
and address questions regarding PA 
Delayed-intervention group
Regular activity pattern
Delayed-intervention group
Education/action-planning session; Fitbit 
Flex; weekly phone calls and emails as 
needed with PT to revisit activity goals 
and address questions regarding PA
First Follow-up Assessment [Week 5]
Bouted MVPA time, bouted sedentary time (SenseWear Mini Armband), KOOS, PIH, 
Adverse Events
Immediate-intervention group
Reduced intervention (continue Fitbit use, 
PT available by email)
Second Follow-up Measures [Week 10]
Bouted MVPA time, bouted sedentary time (SenseWear Mini Armband), KOOS, PIH, 
Adverse Events
Fig. 1 TRACK-OA study flowchart. Acronyms: PA physical activity, PT physiotherapist, MVPA moderate-to-vigorous physical activity, KOOS Knee
Injury and Osteoarthritis Outcome Score, PIH Partners in Health Scale
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ician diagnosis of knee OA, and time since onset are
collected to describe the sample and compare group
randomization at baseline.
Feasibility data
To address the primary objective, data relating to trial
feasibility will be collected. As suggested by Thabane
et al. [36], these data will be been organized according
to process, resources, management, and scientific issues.
Setting benchmarks for feasibility data is beneficial to in-
form larger-scale assessments of this intervention in the
future [36]. Thus, benchmark criteria for success were
set in accordance with the goals of an upcoming proof-of-concept study featuring the present intervention (see
Table 2). Detailed information on the recruitment
process will be collected, including the number of indi-
viduals who contacted us, the source of recruitment, and
the reason for non-eligibility or withdrawal of interest.
Adherence to study protocols (education and training
session attendance, telephone follow-up, Fitbit use, out-
come measure collection) will be assessed for each par-
ticipant by determining whether a participant completed
each component of the study. It has been determined
that at least 4 days of data are required to obtain accur-
ate estimates of PA participation from the SenseWear
armband [37]. Time to complete online questionnaires
will be collected from the online survey system. As the
Table 1 An example of applying the PAR-Q to determine eligibility for the randomized controlled trial
PAR-Q questions Action
General health section
6. Do you currently have (or have had within the past 12 months) a bone, joint, or soft
tissue problem that could be made worse by becoming more physically active?
If “yes” due ONLY to knee OA, answer follow-up questions
1a and 1b of PAR-Q
If “yes” due to other problems, complete entire
follow-up section
Follow-up section
1a. Do you have difficulty controlling your condition with medications or other
physician-prescribed therapies?
If “yes”, the person will require physician clearance
If “no”, the person passes this criterion
1b. Do you have joint problems causing pain, recent fracture or fracture caused by
osteoporosis or cancer, displaced vertebra, and/or spondylolysis/pars defect?
If “yes” ONLY to knee OA causing pain, then ask
clarifying questions below
If “yes” to other conditions, the person will require
physician clearance
Clarifying questions
1. How severe are your symptoms after physical activity? If mild symptoms for <2 h, no physician clearance
necessary
2. After physical activity, do your symptoms last longer than 2 h? Otherwise, require physician clearance
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study is a concern, extremely high equipment retention
and reliability is required. Management issues such as
unforeseen challenges with the host location, study
personnel, or data collection that challenge study logis-
tics or success will be carefully documented. Safety is-
sues and adverse events will be tracked throughout the
study (see “Risk management” subsection below). Feasi-
bility data will be tracked and logged in a detailed ad-
ministrative database and summarized for presentation
at study completion. Treatment effect and variance esti-
mates will be calculated in order to inform sample size
calculations for the larger trial. These calculations willTable 2 Feasibility data to be collected and criteria for success
Feasibility data
category
Item of interest Success criteria
Process Recruitment rate 2 participants/week
Consent rate ≥90 %
Dropout rate ≤10 %
Adherence to
protocols
4 days × 20 h for each SenseWear
week; 100 % completion of online
questionnaires; mean 5 days/week
of Fitbit use
Resources Equipment
loss/reliability
100 % equipment retention
Personnel Sufficient personnel to execute the
trial efficiently
Management Location, logistics,
personnel, data
No criteria set
Scientific Intervention effect,
variation, safety
No criteria setbe carried out assuming a randomized trial with two
equal-sized groups, a two tailed significance threshold
(alpha) of 0.05, and power of 0.8 to detect a significant
result between groups on bouted MVPA and sedentary
time outcomes.
Patient-centered outcome measures
Primary outcome
Bouted MVPA time Bouted MVPA time will be mea-
sured by the BodyMedia SenseWear® Mini armband
(Pittsburgh, PA, USA). The SenseWear armband uses
multi-modal information and proprietary algorithms to
estimate 24-h free-living activity levels (steps, energy ex-
penditure, vigorousness of activity). Measurements are
recorded in 1-min epochs from the device’s triaxial ac-
celerometer and sensors detecting galvanic skin re-
sponse, skin temperature, and heat flux. It is initialized
using the proprietary SenseWear software, and the arm-
band is placed comfortably on the upper triceps and
worn all hours of the day except during water-based
activities. The SenseWear assesses PA vigorousness in
terms of metabolic equivalent of task (MET). Activ-
ities ≥3.0 METs are considered MVPA, thus MVPA is
operationalized as any activity that generates an out-
put of ≥3.0 METs for bouts of 10 min or more as
assessed by the SenseWear armband. Bouts of MVPA
lasting ≥10 min are selected as the outcome measure
of interest (as opposed to total MVPA time) because
of the health promoting benefits of this activity pat-
tern as recommended by national PA guidelines [14].
Allowing for up to a 2-min drop below MVPA
threshold has been proposed as a reasonable approach
for coping with real-world scenarios that may interrupt
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1 min while walking) [38] and has been employed in
the national PA assessment studies using accelerome-
ters [39, 40]. Thus, dropping below 3.0 METs for
more than 2 min within a bout of activity lasting
10 min or more will constitute the end of a bout of
MVPA [41].
Secondary outcomes
Bouted sedentary time Sedentary behaviour is defined
as any waking behaviour characterized by an energy
expenditure ≤1.5 METs while sitting or reclining [42].
Because prolonged sedentary behaviour is of primary
concern [23], sedentary time is operationalized as any
wakeful (e.g. non-sleeping) behaviour generating ≤1.5
METs for a continuous bout of ≥20 min as assessed
by the SenseWear armband.
Disease status Measures of knee OA disease status are
assessed with the Knee Injury and OA Outcome Score
(KOOS). The KOOS questionnaire was developed for
use in a population recovering from knee injury but has
been shown to be a reliable and valid measure of knee
status for the OA population [43–45]. The questionnaire
makes use of five separately interpreted subscales that
assess (1) pain, (2) other symptoms, (3) function in daily
life, (4) function in sport and recreation, and (5) knee-
related quality-of-life. Each of these subscales is assessed
by a five-point Likert scale from 0 to 4, with 0 being “No
Problems” and 4 being “Extreme Problems”. Each sub-
scale score is transformed to a 0–100 scale, with 0 repre-
senting no knee problems and 100 representing extreme
knee problems. The KOOS contains all items from the
Western Ontario McMaster OA Index [46] in its ori-
ginal form but also includes questions about function-
ing in sports and recreation as well as quality of life,
both particularly relevant for the purposes of this inter-
vention [47].
Disease self-management The Partners in Health Scale
(PIH) is used to assess changes in participant percep-
tions of self-management ability. The PIH was developed
to provide a generic tool for objective assessment of pa-
tient self-management skill to provide more targeted
self-management interventions to those who most need
it. The self-rated scale includes 12 items that probe six
principles of successful chronic disease self-management,
including whether patients (1) have knowledge of their
condition; (2) follow a treatment plan agreed on with
healthcare professionals; (3) actively share in decision-
making with healthcare professionals; (4) monitor and
manage signs and symptoms of their condition; (5) man-
age the impact of conditions on the physical, emotional,
and social aspects of life; and (6) adopt lifestyles thatpromote health. Each item is rated on an eight-point
scale, with 0 indicating the highest self-management
and 8 indicating the lowest self-management (min-max
0–96). The PIH has been shown to have good internal
consistency (Cronbach’s α = 0.82) and construct validity
and is a suitable outcome measure for measuring
change in patient self-management knowledge and be-
haviour over time [48].
Assessments
Assessment of outcome measures will occur at three
time points—baseline (T0), week 5 (T1), and week 10
(T2)—with the exception of demographic information
(collected at baseline only) and adverse events (collected
at T1 and T2 only). Both the KOOS and PIH will be
uploaded to an online survey system hosted on a se-
cure local server at Arthritis Research Canada, and
the SenseWear armbands will be delivered to partici-
pants prior to each data collection week.
Randomization
Once informed consent is received and baseline mea-
sures have been collected, participants will be randomly
assigned to one of two groups (immediate-intervention
group or delayed intervention group). As per the
stepped-wedge design, the delayed-intervention group
will receive the intervention after a 5-week waiting
period (i.e. immediately following T1 follow-up assess-
ment; see Fig. 2). A study statistician (CHG) not in-
volved in the day-to-day operation of the trial will
randomly assign participants in blocks to each group
using a computer-based random number generator and
a 1:1 allocation ratio. Block sizes will be concealed from
study staff and randomly varied to prevent prediction of
group allocation. The statistician will pass group alloca-
tions back to study research coordinators (CC, NG) who
will arrange for intervention delivery as appropriate.
Group assignments will be accessible only to the study
research coordinators.
Intervention
Education and training session The education and
training session are delivered at the Mary Pack Arthritis
Center by a physiotherapist and research staff member
to groups of two to four participants. The education
module runs for roughly 40 min. A study physiotherapist
leads a discussion on the causes and nature of knee OA,
cornerstone treatments of the disease, and the role of
PA and exercise in the management of OA. Common
myths about knee OA are discussed and dispelled (e.g.
“exercise makes my knee OA worse”), and a discussion
of various types of PA and exercise appropriate for indi-
viduals with the condition are given. In addition, the
emerging risks of a sedentary lifestyle are presented, and
Immediate-intervention
group
Delayed-intervention
group
Baseline T1 T2
Data collection
Intervention period
Control period
Fig. 2 TRACK-OA randomization diagram. T1 data collection occurs during week 5; T2 data collection during week 10
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Finally, symptom-management strategies are discussed,
including how to manage common problems that may
arise when becoming active. Increasing activity by “listen-
ing to one’s body” is a key message in the education mod-
ule, and ultimately the intent is to increase the
participant’s knowledge about how to be physically active
while having knee OA. Following the education module,
the Fitbit Flex is given to each participant and 30-min
training is provided. Participants then work individually
with the physiotherapist to set personalized PA goals and
create a weekly action plan. This component of the inter-
vention is derived from Brief Action Planning—a struc-
tured, patient-centered method of setting goals and
developing action plans based on the principles of motiv-
ational interviewing. Brief Action Planning first evokes
a participant’s ideas of goals that are personally suitable,
builds a specific action plan, and finishes by evoking a
confidence statement (0–10 scale) [49]. A “barrier iden-
tification/problem solving” step was also added to the
Brief Action Planning framework, which the physiother-
apist will use to direct participants to set goals related to
increasing MVPA participation and interrupting sedentary
time. The education and training session will take an esti-
mated 1.5 h.Fitbit flex Following the education and training session,
participants will be asked to wear the Fitbit 24 h/day
(unless charging) for the remainder of the study. The
Fitbit Flex is a removable tracker (housing a triaxial ac-
celerometer and five-light LED display) inside of a wrist-
band worn on the non-dominant wrist. The Fitbit user-
interface is an easy-to-use web-based application that
graphically displays a user’s activities over the course of
the day including total steps taken, calories burned, and
distance traveled. Interaction with the user-interface
may occur on a self-directed basis.Telephone follow-up Participants will be asked to share
their Fitbit activity data with the physiotherapist they
work with during the education session. This is accom-
plished using Fitbit’s online social networking function
where users can privately share Fitbit activity “profile”
with Fitbit “Friends”. Participants add the physiotherap-
ist as a “Friend”, thus allowing the physiotherapist to
view the participant’s activity data. These data will be
used to inform the content of a 20-min weekly phone
call to each participant from the physiotherapist (for the
first 4 weeks of the intervention only). Like the goal set-
ting portion of the education session, these conversa-
tions are derived from a Brief Action Planning protocol
and are designed to respect participant autonomy while
increasing confidence in PA participation. Furthermore,
the physiotherapist may be contacted by email to ad-
dress participant questions throughout the duration of
the intervention as they arise.Risk management and safety monitoring
Adverse events during the study will be tracked both by
self-report on the online outcome measure questionnaire
and by study physiotherapists during follow-up phone
calls. In the online questionnaire, participants are asked
if they experienced any negative outcomes (presented as
a list of outcomes and allowing for free form entry at
the end of the questionnaire) as a result of becoming
more physically active since their enrollment in the
study. They are asked to specify when the event oc-
curred and if the event was experienced before. In an
open-format response, participants are asked to describe
the symptoms they experienced, any medical help they
sought as a result, and any other relevant information.
Any participants reporting adverse events will be imme-
diately contacted and, if necessary, assessed by a study
physiotherapist before being referred for appropriate
care as needed.
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Data will be stored in confidential servers on the Arthritis
Research Canada premises. Participant ID’s are assigned
upon enrollment, with a secondary ID assigned upon
randomization. To ensure anonymity, participants are
referred to by their study ID in emails and verbal com-
munications where necessary. Access to all computer
files with participant information will be limited to the
study team, and individual files will be password pro-
tected. SenseWear data will be downloaded by a staff
member (JY), who is blinded to participant’s group as-
signment, using SenseWear Professional Software 8.0,
and exported to Excel (Microsoft, Redmond, WA) and
processed in MatLab (The MathWorks, Inc., Natick,
MA, USA). Data quality will be monitored on an on-
going basis by study staff, and backups will be saved
weekly. The final de-identified data set will be provided
to a blinded study statistician for analysis.
Sample size calculation
As pilot studies are primarily concerned with feasibility
and generating estimates that will inform future studies’
power and sample size calculations, sample size, or power
calculations were not deemed necessary for this trial [47].
A convenience sample of 36 participants was estimated to
allow sufficient piloting of study protocols and estimates
of feasibility measures to inform a future trial.
Statistical analysis
Descriptive measures will be tabulated and summarized
by count, percentage, or mean, and 95 % CI and com-
pared for differences between groups. Integrity of the
randomization process will be monitored. SenseWear
armband measurements for each time point will be
considered valid if they include at least 4 days with at
least 20 h of wear time each day [50]. Feasibility data
will be collated and compared against benchmarks for
success. When assessing preliminary intervention effi-
cacy, the stepped-wedge design allows for analyses of
differences between groups as well as temporal pat-
terns. Changes in bouted MVPA, bouted sedentary
time, KOOS score, and PIH score will assessed by a
multiple regression model including variables for
group, time, and group-time interaction. The effect of
blocking will be considered in the analysis. Planned
comparisons will be used to compare group means for
differences at first follow-up (week 5) and to test for a
delay effect and for temporal changes intervention effi-
cacy. All analyses will be conducted using IBM SPSS
Version 20 (Armonk, NY, USA).
Dissemination and knowledge translation
Patient collaborators from the Arthritis Research Canada’s
Arthritis Patient Advisory Board (APAB) were consultedduring the study design process to provide insight
into patient values and concerns regarding physical
activity and use of wearable activity trackers. Open
channels of communication will be maintained with
APAB during the study for patient perspectives on
challenges or changes to study protocol. Study results
will be featured on the Arthritis Research Canada
website, as well as the lab website hosted through the
University of British Columbia. Furthermore, results
will be disseminated through the Arthritis Research
Canada monthly e-newsletter and through a presenta-
tion at an APAB monthly meeting. Results will be
shared with the scientific community by way of publi-
cation and conference presentation.
Discussion
This paper presents a pilot RCT protocol to assess the
feasibility of an intervention designed to increase MVPA
and decrease sedentary time in a sample from the knee
OA population. The program guides participants in set-
ting personally relevant activity goals based on their
preferences and level of ability and slowly increase PA
participation over time. It is hoped that this patient-
centered approach of gradually integrating greater ac-
tivity into one’s existing life framework may enhance
adherence to PA over time, a recognized challenge [6].
A potential limitation of this intervention is the techno-
logical skill requirement, which could act as a barrier to
some individuals. However, there are several strengths.
First, the use of the stepped-wedge trial design pre-
serves the integrity of a randomized experiment while
not withholding a potentially beneficial intervention
from study participants. Conventional cross-over de-
signs are impractical for PA promotion interventions as
washout-period lengths have not been established and
may be of considerable duration. Furthermore, the
stepped-wedge design allows for assessment of lag-time
effects, which may be relevant for people with arthritis
as they may experience delays in the delivery of care.
Piloting this trial format will be important in determin-
ing any feasibility challenges (e.g. delayed-group partici-
pant dropout) that may need addressing in future
studies. Second, there is evidence to suggest the em-
phasis on action-oriented behavioural strategies for PA
promotion may be more effective than cognitive or
educational methods [24]. Third, the enhanced ability
for participants to self-monitor goal progress and re-
ceive ongoing feedback that comes through the use of
an activity tracker may increase awareness of PA behav-
iour and enhance activity-related self-efficacy, a known
determinant of PA [51]. Fourth, the sharing of Fitbit
data between participants and study physiotherapists
encourages accountability and provides an opportunity
to deliver more specific and personally relevant follow-
Clayton et al. Pilot and Feasibility Studies  (2015) 1:30 Page 9 of 10up support to participants throughout the study. The
feasibility metrics such as recruitment rate, dropout rate,
adherence, and resource requirements collected in this
study will be used to estimate the time, resources, and
sample size required for a full-scale RCT. Furthermore,
the experience gained from executing study protocols and
the feedback provided from staff and participants will
allow for improvement and refinement of trial elements
and procedures to ensure the success of a future study to
test the efficacy of this intervention. Pending the results of
this pilot study, a full-sized trial will be designed and
conducted in the Greater Vancouver Area in late 2015
and early 2016.
Trial status
The trial began recruitment in 20 February 2015 and is
presently open for recruitment. Recruitment will close
when 36 participants have been randomized. It is antici-
pated this target will be met in August 2015.
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